AdaptHealth Corp. (AHCO) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

AdaptHealth Corp. (AHCO) Healthcare & Pipeline Overview

AdaptHealth Corp. delivers home medical equipment and services, including sleep therapy and diabetes care, serving a broad patient base covered by Medicare, Medicaid, and commercial insurance. With a focus on chronic care, AdaptHealth addresses the growing demand for in-home medical solutions, positioning itself within the expanding healthcare services sector.

What Is the Investment Thesis for AHCO?

AdaptHealth Corp. presents a compelling investment case based on its position in the growing home medical equipment market and its focus on chronic care. The company's financial profile shows a market capitalization of $733M and a P/E ratio of 8.4. AdaptHealth's free cash flow of $0.23 billion demonstrates its ability to generate cash. Growth catalysts include the increasing prevalence of chronic diseases, the aging population, and the shift towards home-based healthcare. However, investors should be aware of potential risks, including regulatory changes, reimbursement pressures, and competition from other HME providers. With a beta of 1.72, the stock exhibits higher volatility compared to the market. AdaptHealth's ability to expand its product offerings, geographic reach, and partnerships will be critical to its long-term success.

Based on FMP financials and quantitative analysis

AHCO Key Highlights

Market Cap of $733M indicates substantial company size within the medical devices industry.

• P/E Ratio of 8.4 suggests the company may be undervalued compared to its earnings.
• Free Cash Flow of $0.23B demonstrates strong cash generation capabilities.
• Gross Margin of 5.4% indicates potential areas for improvement in cost management and pricing strategies.
• Beta of 1.72 suggests higher volatility compared to the market, potentially offering higher returns but also increased risk.

Who Are AHCO's Competitors?

AHCO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AHCO's Key Strengths?

Comprehensive range of home medical equipment and services.

• Established relationships with payors.
• Extensive distribution network.
• Focus on chronic care management.

What Are AHCO's Weaknesses?

Low Gross Margin of 5.4%

• Negative Profit Margin of -2.8%
• High Beta of 1.72 indicates volatility
• Dependence on reimbursement rates from government and commercial payors.

What Could Drive AHCO Stock Higher?

Increasing prevalence of chronic diseases driving demand for home medical equipment.

• Aging population requiring more home-based healthcare services.
• Potential for strategic acquisitions to expand market share.
• Partnerships with healthcare providers to drive referrals.
• Expansion of telehealth services to enhance patient engagement.

What Are the Key Risks for AHCO?

Financial-distress signal — its Altman Z-Score of 0.51 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-5.1%) — the business is not currently generating profit on shareholder capital.
• Regulatory changes impacting reimbursement rates.
• Competition from other HME providers.
• Technological advancements rendering existing equipment obsolete.
• Economic downturn affecting patient access to healthcare.
• Dependence on Medicare and Medicaid reimbursement policies.

What Are the Growth Opportunities for AHCO?

• Expansion of Sleep Therapy Services: The increasing prevalence of sleep apnea presents a significant growth opportunity for AdaptHealth. By expanding its sleep therapy services, including CPAP and bi-PAP equipment and supplies, AdaptHealth can capture a larger share of this market. The global sleep apnea devices market is projected to reach $11.2 billion by 2027, driven by rising awareness and diagnosis rates. AdaptHealth can leverage its existing infrastructure and expertise to capitalize on this growing demand. This expansion can be achieved through strategic acquisitions, partnerships with sleep clinics, and increased marketing efforts.
• Growth in Diabetes Care: The rising incidence of diabetes creates a substantial market for AdaptHealth's diabetes care products and services, including continuous glucose monitors and insulin pumps. The global diabetes care devices market is expected to reach $37.9 billion by 2028. AdaptHealth can expand its presence in this market by offering a wider range of diabetes management solutions, enhancing patient education and support, and partnering with endocrinologists and diabetes educators. This growth opportunity aligns with the increasing focus on remote patient monitoring and personalized diabetes care.
• Strategic Acquisitions: AdaptHealth can pursue strategic acquisitions to expand its geographic reach, product offerings, and customer base. By acquiring smaller HME providers, AdaptHealth can consolidate its market position and achieve economies of scale. The fragmented nature of the HME industry provides ample opportunities for acquisitions. These acquisitions can also provide access to new technologies, specialized services, and skilled personnel. Careful due diligence and integration are essential to ensure the success of these acquisitions.
• Partnerships with Healthcare Providers: Collaborating with hospitals, physician groups, and other healthcare providers can drive referrals and increase patient access to AdaptHealth's products and services. By establishing strong relationships with these providers, AdaptHealth can become an integral part of the patient care continuum. These partnerships can involve joint marketing initiatives, shared data analytics, and integrated care pathways. The trend towards value-based care further incentivizes healthcare providers to partner with HME providers like AdaptHealth to improve patient outcomes and reduce costs.
• Expansion of Telehealth Services: Integrating telehealth services into its offerings can enhance patient engagement, improve adherence to therapy, and reduce healthcare costs. AdaptHealth can leverage telehealth to provide remote monitoring, virtual consultations, and online education to patients. The telehealth market is experiencing rapid growth, driven by technological advancements and increasing acceptance among patients and providers. By offering telehealth services, AdaptHealth can differentiate itself from competitors and attract a new generation of tech-savvy patients.

What Are AHCO's Competitive Advantages?

• Established relationships with Medicare, Medicaid, and commercial insurance payors.
• Comprehensive product offerings covering a wide range of home medical equipment and supplies.
• Extensive network of distribution centers and service locations across the United States.
• Expertise in providing ongoing support and services to patients in their homes.

What Does AHCO Do?

AdaptHealth Corp. was formed to address the increasing need for accessible and comprehensive home medical equipment and services. The company provides a range of products and services, including sleep therapy equipment for obstructive sleep apnea, medical devices for diabetes management (such as continuous glucose monitors and insulin pumps), and general home medical equipment for patients discharged from acute care facilities. AdaptHealth also offers oxygen and related chronic therapy services, along with supplies for wound care, urological needs, incontinence, ostomy, and nutritional support. AdaptHealth serves a diverse patient base, primarily beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company operates across the United States, focusing on delivering personalized care and support to patients in their homes. AdaptHealth's business model centers on providing essential medical equipment and supplies, coupled with ongoing support and services, to improve patient outcomes and reduce healthcare costs. The company's growth strategy involves expanding its product offerings, geographic reach, and partnerships with healthcare providers and payors. AdaptHealth's commitment to quality and patient satisfaction has enabled it to establish a strong presence in the home medical equipment market.

What Products and Services Does AHCO Offer?

• Provides sleep therapy equipment and supplies for individuals with obstructive sleep apnea.
• Offers medical devices and supplies for diabetes management, including continuous glucose monitors and insulin pumps.
• Delivers home medical equipment to patients discharged from acute care facilities.
• Provides oxygen and related chronic therapy services in the home.
• Supplies wound care, urological, incontinence, ostomy, and nutritional products.
• Serves beneficiaries of Medicare, Medicaid, and commercial insurance payors.
• Offers home and related services to support patients' medical equipment needs.

How Does AHCO Make Money?

• Generates revenue through the sale and rental of home medical equipment and supplies.
• Receives reimbursement from Medicare, Medicaid, and commercial insurance payors.
• Provides ongoing support and services to patients to ensure proper equipment usage and adherence to therapy.

What Industry Does AHCO Operate In?

AdaptHealth Corp. operates in the home medical equipment (HME) industry, which is experiencing growth driven by an aging population, increasing prevalence of chronic diseases, and a shift towards home-based healthcare. The market is competitive, with companies like ResMed and Lincare Holdings also vying for market share. AdaptHealth differentiates itself through its comprehensive product offerings, focus on chronic care, and partnerships with healthcare providers and payors. The industry is subject to regulatory oversight and reimbursement pressures, which can impact profitability. The global home healthcare market is projected to reach $365 billion by 2028, presenting significant growth opportunities for AdaptHealth.

Who Are AHCO's Key Customers?

• Individuals suffering from obstructive sleep apnea.
• Patients with diabetes requiring medical devices and supplies.
• Patients discharged from acute care facilities needing home medical equipment.
• Chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

AdaptHealth Corp. (AHCO) Valuation Context

Valued at $733M, AHCO is classified as a small-cap stock. Relative to its peer group, AHCO's quantitative score of 26/100 is below the peer average of 81/100.

AHCO Revenue & Earnings Trend

In Q2 2026, AHCO generated $740.3M in top-line revenue, marking a sequential decrease of 9.7%. The company recorded a net loss of $133.9M, with diluted EPS of $-0.99. Revenue has contracted over three consecutive quarters, which investors in this small-cap Healthcare stock should monitor closely. Across the four most recent quarters, AHCO averaged $-0.42 in diluted EPS.

Company Profile

AdaptHealth Corp. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Plymouth Meeting, US. The company is led by CEO Suzanne Foster. AHCO has traded publicly since 2018.

Return on equity for AdaptHealth Corp. stands at -5.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -1.8%, showing how much profit it generates from its asset base. Its free cash flow yield is 14.4%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.92 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -6.0%, the inverse of the P/E and a quick read on earnings relative to price.

AdaptHealth Corp.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.51 places it in the distress zone, a signal of elevated financial risk.

Wall Street analysts project AdaptHealth Corp. revenue of about $2.96B for fiscal 2026, with EPS near $-0.02. The estimate reflects 4 contributing analysts.

AHCO Financials

AHCO Latest News

AHCO Analyst Consensus

AHCO MoonshotScore

What Investors Ask About AdaptHealth Corp. (AHCO) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources